Alcidion Group Ltd (ASX: ALC) Share Price and News

Ms Wilson is an experienced company director with private, ASX listed and not-for-profit organisations. In her previous executive career, she held global leadership roles in marketing communication, investor relations, and corporate affairs. She has experience in ESG stakeholder communication, issues, crisis and risk management, transactions, and investor relations. She has worked with multinational and growth companies in technology, healthcare, retail, and professional services sectors. Rebecca is experienced in leading companies during important commercial activation phases working with CEOs as both an advisor and non-executive director to develop and execute effective business strategy that supports accelerated and sustained growth. She's a Non-Executive Director of NFP, The Tomisich Foundation and Veski.

Mr Smart is a global digital health leader with over 30 years of experience leading transformational change in organisations. Will has a track record of driving politically sensitive and operationally critical initiatives, enhancing organisational performance. Based in the United Kingdom, Will is currently Digital Non-Executive Director, Great Western Hospitals NHS Foundation Trust and was previously the CIO for Health and Social Care for England. In that role, Will provided advice to the Secretary of State for Health and Social Care and developed and delivered national strategies on information, technology and informatics. He has held executive roles in several NHS Trusts including as Group Chief Information Officer, Royal Free London NHS Foundation Trust. Until recently, Will served as the Global Director of External Relations, Dedalus Group where he had responsibilities across the UK and Europe and led the launch of their European built Electronic Patient Record (EPR) solution into Ireland and the UK. He is member of the Risk Committee.

Ms Doyle, since July 2018, has been the Group Managing Director and Chief Executive Officer of the Alcidion Group, a company dedicated to providing smart technology to the health sector. Kate leads the business globally with a goal of developing mutually beneficial relationships with customers, partners and investors. Kate has 25 plus years of digital health sector experience and has been involved in procurements and implementations of healthcare information technology across Australia, New Zealand, the United Kingdom and South-East Asia. Her background includes management roles at healthcare software firms where she has driven strategic product direction, global sales and operations. She believes technology can enable the transformation of healthcare delivery. Kate is currently a Non-Executive Director of ANDHealth, Australia's provider of accelerator, incubator and commercialisation programs for digital health technology companies.

Mr Sharp originally commencing his career as a lawyer and has over 25 years senior executive experience in investment banking and corporate finance. From 2012-2020, Danny was an Executive Director of Corporate Finance at Canaccord Genuity where he led dozens of equity capital market transactions and corporate finance advisory projects across the healthcare, life sciences, technologies, financial services and general industrials sectors. Prior to his executive role at Canaccord, Danny headed the corporate finance division at two of Australia's independent Investment Banking/Stockbroking firms. Danny has managed the IPOs, capital raisings and corporate advisory activities for ASX listed companies in the healthcare, technologies and general industrials sectors. He is connected to strong networks of institutional, family office and investors both in Australia and overseas. Danny is currently Non-Executive Chair of VetScripts Pty Ltd and a member of the Investment Committee for the Baker Heart and Diabetes Institute Foundation. He is chair of the Risk Committee.

Mr Way commenced his career as a nurse in the UK National Health Service (NHS) and after a range of clinical positions, moved first into nursing leadership and then in the late 1980's into general management. Andrew has held several senior executive roles in research-focussed hospitals in both the UK NHS and Australia. He has been a Chief Executive for nearly 25 years, most recently as the CEO of Alfred Health in Melbourne, Victoria, finishing in 2024. Andrew has led several hospitals through clinical and non-clinical digital transformations. Andrew is currently Board Chair of HealthShare Victoria and a Director of Australian College of Health Service Management (ACHSM). He was Interim CEO at the Royal Australian New Zealand College of Psychiatrists between December 2024 and July 2025. He continues to hold a range of other health related advisory roles. He is member of the Risk Committee.

-

-

-